Specific reduction of plasma large, light low-density lipoprotein by a bile acid sequestering resin, cholebine (MCI-196) in type II hyperlipoproteinemia

This publication has 29 references indexed in Scilit:

• Effects of simvastatin on plasma lipoprotein subfractions, cholesterol esterification rate, and cholesteryl ester transfer protein in type II hyperlipoproteinemia
  Atherosclerosis, 1995
• ApoB metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
• Effects of bezafibrate therapy on subfractions of plasma low-density lipoprotein and high-density lipoprotein, and on activities of lecithin: cholesterol acyltransferase and cholesteryl ester transfer protein in patients with hyperlipoproteinemia
  Atherosclerosis, 1994
• Effects of simvastatin on apoB metabolism and LDL subfraction distribution.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
• Effects of eicosapentaenoic acid on plasma lipoprotein subfractions and activities of lecithin: cholesterol acyltransferase and lipid transfer protein
  Atherosclerosis, 1991
• Effects of probucol on plasma lipoprotein subfractions and activities of lipoprotein lipase and hepatic triglyceride lipase
  Atherosclerosis, 1991
• Kinetic heterogeneity of low density lipoproteins in primary hypertriglyceridemia.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1986
• Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.
  Circulation, 1984
• Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein Catabolism
  New England Journal of Medicine, 1980
• Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia.
  Circulation, 1979